(Q40242574)

18 September 2017

title

Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice (English)

1 reference

18 September 2017

Vaccinia virus

1 reference

Hung CF

1

1 reference

18 September 2017

Tsai YC

2

1 reference

18 September 2017

He L

3

1 reference

18 September 2017

Coukos G

4

1 reference

18 September 2017

Fodor I

5

1 reference

18 September 2017

Qin L

6

1 reference

18 September 2017

Levitsky H

7

1 reference

18 September 2017

Wu TC

8

1 reference

18 September 2017

publication date

17 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

14

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

20-29

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302840

18 September 2017

exact match

0 references

cites work

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Systemic tumor targeting and killing by Sindbis viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcino

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Subcutaneous administration of a recombinant vaccinia virus vaccine expressing multiple envelopes of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Vaccine strategies for human papillomavirus-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Low-dose vaccinia virus-mediated cytokine gene therapy of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Vaccinia virus mediated p53 gene therapy for bladder cancer in an orthotopic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

Selection of therapy for stage III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

inferred from DOI database lookup

7 January 2021

based on heuristic

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302840

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302840

1 reference

Dimensions Publication ID

18 September 2017

1044443511

0 references

1 reference